Cronos
Cronos
CRON
NASDAQ
2.11
USD
4.98%
About
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products.
The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s international brand portfolio includes Spinach, PEACE NATURALS, and Lord Jones. The Lord Jones are hemp-derived cannabidiol (CBD) brand.
Its Lord Jones Hash Fusions is a line-up of premium ice water hash infused pre-rolls. Its PEACE NATURALS offers Peppermint CBD, a blend of CBD extract, quality medium-chain triglycerides (MCT) oil, and a hint of natural peppermint flavor..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 112.5K |
| Three Month Average Volume | 2.0M |
| High Low | |
| Fifty-Two Week High | 2.97827 USD |
| Fifty-Two Week Low | 1.62135 USD |
| Fifty-Two Week High Date | 16 May 2024 |
| Fifty-Two Week Low Date | 23 Oct 2023 |
| Price and Volume | |
| Current Price | 2.10845 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -8.71% |
| Thirteen Week Relative Price Change | -18.36% |
| Twenty-Six Week Relative Price Change | 1.72% |
| Fifty-Two Week Relative Price Change | -3.88% |
| Year-to-Date Relative Price Change | -1.80% |
| Price Change | |
| One Day Price Change | 2.02% |
| Thirteen Week Price Change | -14.41% |
| Twenty-Six Week Price Change | 10.18% |
| Five Day Price Change | -3.50% |
| Fifty-Two Week Price Change | 10.58% |
| Year-to-Date Price Change | 9.39% |
| Month-to-Date Price Change | -10.88% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 2.70762 USD |
| Book Value Per Share (Most Recent Quarter) | 2.60179 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 2.65311 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 2.55235 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.14979 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.21501 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.2505 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -69585.83474 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -69585.83474 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.17215 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.14128 USD |
| Normalized (Last Fiscal Year) | -0.1269 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.17215 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.14128 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.18229 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.14141 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 2.12145 USD |
| Cash Per Share (Most Recent Quarter) | 2.08324 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.15362 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.12655 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 0.02969 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -205 |
| Cash Flow Revenue (Trailing Twelve Months) | 12 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -61.24% |
| Pretax Margin (Last Fiscal Year) | -84.44% |
| Pretax Margin (5 Year) | 157.06% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 13.65% |
| Gross Margin (Trailing Twelve Months) | 16.37% |
| Gross Margin (5 Year) | -10.54% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -123.97% |
| Operating Margin (Trailing Twelve Months) | -121.76% |
| Operating Margin (5 Year) | -380.77% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -80.74% |
| Net Profit Margin (Trailing Twelve Months) | -56.97% |
| Net Profit Margin (5 Year) | 147.07% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | 28.27% |
| Tangible Book Value (5 Year) | 50.64% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 45.95% |
| Revenue Growth (3 Year) | 48.40% |
| Revenue Change (Trailing Twelve Months) | 31.88% |
| Revenue Per Share Growth | 26.62% |
| Revenue Growth (5 Year) | 23.14% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -50.99% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -57.89% |
| EPS Change (Trailing Twelve Months) | 54.68% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 1 |
| Price to Tangible Book (Most Recent Quarter) | 1 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 71 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -1,144,461,000 |
| Net Debt (Last Fiscal Year) | -1,162,460,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 10 |
| Price to Sales (Trailing Twelve Months) | 8 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 10 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 2 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 1 |
| Price to Book (Most Recent Quarter) | 1 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 22 |
| Quick Ratio (Most Recent Quarter) | 27 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 23 |
| Current Ratio (Most Recent Quarter) | 28 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -61,177,260 |
| Free Cash Flow (Trailing Twelve Months) | 16.3M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -5.99% |
| Return on Assets (Trailing Twelve Months) | -5.13% |
| Return on Assets (5 Year) | 6.43% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -6.23% |
| Return on Equity (Trailing Twelve Months) | -5.22% |
| Return on Equity (5 Year) | 7.21% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -6.27% |
| Return on Investment (Trailing Twelve Months) | -5.26% |
| Return on Investment (5 Year) | 7.11% |